Lexeo Therapeutics, Inc. (LXEO) vs Palisade Bio, Inc. (PALI)
Lexeo Therapeutics, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Lexeo Therapeutics, Inc. and Palisade Bio, Inc. are of similar size ($278.3M and $273.6M). Lexeo Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Lexeo Therapeutics, Inc. has the higher net margin (0.00% vs −4,230.6%) and the lower return on invested capital (−253.5% vs 0.00%). Across the 14 metrics below, Lexeo Therapeutics, Inc. leads on 7 and Palisade Bio, Inc. on 7.
Valuation
Profitability
| Metric | LXEO | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.63% | 65.16% |
| Operating margin | 0.00% | (4,681.99%) | 0.00% |
| Net margin | 0.00% | (4,230.60%) | 0.00% |
| Free cash flow margin | 0.00% | (2,409.27%) | 0.00% |
| Return on equity | (46.76%) | (51.37%) | (57.72%) |
| Return on assets | (40.50%) | (47.68%) | (49.22%) |
| Return on invested capital | (253.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack